Daniela Hernandez
Episode 38
The Science Behind Controversial New Weight Loss Drugs Like Ozempic
Ozempic, Wegovy, Mounjaro—drugs developed to treat diabetes—are being used for cosmetic weight loss
Some drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss. WSJ’s Daniela Hernandez explains how they work, their side effects, and concerns over unintended consequences. Illustration: Elizabeth Smelov
Daniela Hernandez
Daniela Hernandez extends her health and science reporting to cover a variety of relevant subjects from Covid-19 to climate change.
Up Next in Daniela Hernandez
- E41
Metformin and Autophagy: The Cellular Recycling Process Behind Aging
Metformin may have anti-aging properties because of a cellular recycling process called autophagy. WSJ’s Daniela Hernandez explains what autophagy is and why boosting this process might slow aging. Illustration: Elizabeth Smelov - E37
Why Fungi Are the Next Big Global Health Threat
As certain fungi like Candida auris become more widespread throughout the U.S., deaths related to severe fungal infections are rising. WSJ’s Daniela Hernandez explains what you should know. Composite: Noah Friedman - E36
Inflation Brain: Why You Seesaw Between Splurging and Penny-Pinching
Amid high inflation, people are splurging more than ever on luxury items while still penny-pinching on other goods and services like groceries. WSJ's Daniela Hernandez explains why. Photo Composite: David Fang